As Coronavirus Continues to Infect People the FDA Authorizes First Breathalyzer Test To Detect COVID-19
AGN.News Team
April 14, 2022
SILVER SPRINGS, MARYLAND (AGN.News) – On June 30, 1906, the creation of the United States Food and Drug Administration (FDA or USFDA), a federal agency of the Department of Health and Human Services, is responsible for protecting and promoting public health through the control and supervision of food safety and among other products, prescription and over-the-counter pharmaceutical drugs, known as medications, and vaccines.
The continued rise in COVID-19 infection cases has necessitated more ways to detect it. The FDA, in fulfilling its role to protect the country and its public health, has now authorized the first breathalyzer test to detect COVID-19.
On Thursday, April 14, 2022, in a FDA news release. it announced in a Coronavirus (COVID-19) Update entitled: ‘FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples’. This breathalyzer test provides results in less than three minutes. The news release states:
“Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated with a SARS-CoV-2 infection. The test can be performed in environments where the patient specimen is both collected and analyzed, such as doctor’s offices, hospitals and mobile testing sites, using an instrument about the size of a piece of carry-on luggage. The test is performed by a qualified, trained operator under the supervision of a health care provider licensed or authorized by state law to prescribe tests and can provide results in less than three minutes.”
“Today’s authorization is yet another example of the rapid innovation occurring with diagnostic tests for COVID-19,” said Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health. “The FDA continues to support the development of novel COVID-19 tests with the goal of advancing technologies that can help address the current pandemic and better position the U.S. for the next public health emergency.”
The rise in cases of Omicron BA.2 infections in the United States are being reported everyday. The FDA and the Centers for Disease Control and Prevention at CDC.gov and covid.gov provides information on many ways to mitigate the spread of COVID-19 with its many variants.
The CDC provides extensive COVID-19 local Guidance and mitigation information on subjects like self-testing, travel, quarantine & isolation, as well as people with certain medical conditions and much more online: here.
There are many resources available via the Centers for Disease Control website to answer many questions individuals and families are seeking answers at cdc.gov.
COVID-19 PREVENTION
STOP THE SPREAD! GET VACCINATED! VACCINES ARE AVAILABLE FOR FREE!
Everyone is being urged by the Centers for Disease Control (CDC.gov) to get vaccinated, wear masks, practice social distancing, and wash hands as a way to cut down on the transmission rate.
For more information on local responses to the novel coronavirus also called … COVID-19, contact your local healthcare provider, visit coronavirus.gov or visit cdc.gov for the United States response to the coronavirus.
News you can use! Enjoy the best of news from your community by Alphabet Global News.
ALPHABET GLOBAL NEWS
Reliable. Trusted. Local. News.
On Mobile … Fast!
Written by
AGN.News Team
Disclaimer: This post does not represent the views or viewpoint of the owner of AlpLocal.com, AGN News or its representatives or reporters. Any content which references any person, entity or group with similar names, descriptions, or business interest in any geographical location or similar businesses is merely a coincidence and not directed at said business. AGN News is compiled from submissions by contributors or other sources.
